Francesc Palau
Biographic Data
| ID | 6285582 |
|---|---|
| NAME | Francesc Palau |
| GIVEN NAMES | Francesc |
| FAMILY NAME | Palau |
| SIGNATURE | PALAU F |
| AFFILIATIONS | Centre for Biomedical Network Research on Rare Diseases |
| ORCID | 0000-0002-8635-5421 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 1 |
Ethics and Genomic Editing Using the Crispr-Cas9 Technique
The field of genetics has seen major advances in recent decades, particularly in research, prevention and diagnosis. One of the most recent developments, the genomic editing technique Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, has opened the possibility for genetic therapies through genome modification. The technique marks an improvement on previous procedures but poses some serious ethical conflicts. Bioethics is th…
Biomarcadores y medicina personalizada en las enfermedades raras
Las enfermedades raras, más allá de su baja prevalencia, presentan diferencias con las enfermedades comunes. Los biomarcadores se caracterizan por ser herramientas útiles para determinar y evaluar de un modo objetivo procesos biológicos normales, procesos patológicos o la respuesta farmacológica a las intervenciones terapéuticas o a cualquier otra intervención en la atención sanitaria. Como determinantes biológicos de la enfermedad humana y del m…
Ethics and Genomic Editing Using the Crispr-Cas9 Technique
The field of genetics has seen major advances in recent decades, particularly in research, prevention and diagnosis. One of the most recent developments, the genomic editing technique Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, has opened the possibility for genetic therapies through genome modification. The technique marks an improvement on previous procedures but poses some serious ethical conflicts. Bioethics is th…
Biomarcadores y medicina personalizada en las enfermedades raras
Las enfermedades raras, más allá de su baja prevalencia, presentan diferencias con las enfermedades comunes. Los biomarcadores se caracterizan por ser herramientas útiles para determinar y evaluar de un modo objetivo procesos biológicos normales, procesos patológicos o la respuesta farmacológica a las intervenciones terapéuticas o a cualquier otra intervención en la atención sanitaria. Como determinantes biológicos de la enfermedad humana y del m…
Ethics and Genomic Editing Using the Crispr-Cas9 Technique
The field of genetics has seen major advances in recent decades, particularly in research, prevention and diagnosis. One of the most recent developments, the genomic editing technique Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, has opened the possibility for genetic therapies through genome modification. The technique marks an improvement on previous procedures but poses some serious ethical conflicts. Bioethics is th…
Philosophy (2 works) · Philosophy (2 works) · Artificial Intelligence (1 work) · Bioethics (1 work) · Biology (1 work) · Biomedical Ethics and Regulation (1 work) · Cas9 (1 work) · Computational biology (1 work) · Computer Science (1 work) · Conceptualization (1 work)